Fatskills
Practice. Master. Repeat.
Study Guide: Preventive Care: Immunisation Schedules, Cancer Screening, Well-Child Visits
Source: https://www.fatskills.com/nursing-entrance-exams/chapter/preventive-care-immunisation-schedules-cancer-screening-well-child-visits

Preventive Care: Immunisation Schedules, Cancer Screening, Well-Child Visits

By Fatskills Exam Guides Team — the exam nerds behind 28,500+ quizzes and 2.1M practice questions across 500+ global exams.

⏱️ ~7 min read

Preventive Care: Immunisation Schedules, Cancer Screening, Well-Child Visits

A high-density, practical guide for nurses, medical students, and healthcare providers.


What Is This?

Preventive care consists of immunisations, cancer screenings, and well-child visits—proactive measures to prevent disease, detect early-stage conditions, and monitor healthy development. Healthcare providers use these to reduce morbidity, mortality, and healthcare costs while improving population health.

Why use it today? - Immunisations prevent 2–3 million deaths annually (WHO). - Cancer screening reduces mortality by 20–30% for breast, cervical, and colorectal cancers. - Well-child visits catch developmental delays early, improving long-term outcomes.


Why It Matters

Real-World Impact

  1. Disease Prevention – Vaccines eradicated smallpox and nearly eliminated polio.
  2. Early Detection – Screening finds cancers before symptoms appear, increasing survival rates.
  3. Cost Savings – Every $1 spent on childhood vaccines saves $16 in healthcare costs (CDC).
  4. Public Health – Herd immunity protects immunocompromised individuals.
  5. Legal & Ethical Compliance – Many countries mandate immunisations for school entry; malpractice risks arise from missed screenings.

Core Concepts

1. Immunisation Schedules

  • Active vs. Passive Immunity
  • Active: Body produces antibodies (e.g., vaccines).
  • Passive: Pre-formed antibodies (e.g., maternal antibodies, immunoglobulin).
  • Live vs. Inactivated Vaccines
  • Live-attenuated: Weakened pathogen (e.g., MMR, varicella). Contraindicated in pregnancy/immunocompromised.
  • Inactivated: Killed pathogen (e.g., polio, hepatitis A). Safer but may require boosters.
  • Herd Immunity Threshold – % of population immune to prevent outbreaks (e.g., 95% for measles).

2. Cancer Screening

  • Screening vs. Diagnostic Testing
  • Screening: Asymptomatic individuals (e.g., mammogram, Pap smear).
  • Diagnostic: Symptomatic or high-risk individuals (e.g., colonoscopy after positive FOBT).
  • Sensitivity vs. Specificity
  • Sensitivity: % of true positives (e.g., 90% for mammograms).
  • Specificity: % of true negatives (e.g., 95% for Pap smears).
  • Overdiagnosis & False Positives – Can lead to unnecessary stress, biopsies, or treatments.

3. Well-Child Visits

  • Developmental Milestones – Tracked via tools like the Ages & Stages Questionnaires (ASQ).
  • Anticipatory Guidance – Counseling on safety, nutrition, and behavior (e.g., car seats, screen time).
  • Growth Monitoring – Height, weight, head circumference plotted on WHO/CDC growth charts.

How It Works

1. Immunisation Schedules

  • Global Standards: WHO’s Expanded Programme on Immunization (EPI) sets baseline schedules.
  • Country-Specific Adjustments: CDC (U.S.), NHS (UK), and others adapt based on local epidemiology.
  • Vaccine Administration:
  • Route: IM (most), SC (MMR, varicella), oral (rotavirus), intranasal (FluMist).
  • Spacing: Minimum intervals between doses (e.g., 4 weeks between MMR doses).
  • Catch-Up Schedules: For missed doses (e.g., HPV vaccine up to age 45).

Example Schedule (U.S. CDC 2024): | Age | Vaccines | |--------------|--------------------------------------------------------------------------| | Birth | Hepatitis B (HepB) | | 2 months | DTaP, Hib, IPV, PCV13, Rotavirus, HepB (2nd dose) | | 12 months | MMR, Varicella, HepA, PCV13 (4th dose) | | 4–6 years | DTaP (5th dose), IPV (4th dose), MMR (2nd dose), Varicella (2nd dose) | | 11–12 years | Tdap, HPV, MenACWY | | 16 years | MenACWY (2nd dose), MenB (optional) |

2. Cancer Screening

  • Breast Cancer:
  • Mammogram: Biennial for ages 50–74 (USPSTF). Earlier if high-risk (e.g., BRCA mutation).
  • MRI: For high-risk women (e.g., >20% lifetime risk).
  • Cervical Cancer:
  • Pap Smear: Every 3 years (21–29); every 5 years with HPV test (30–65).
  • HPV Vaccine: Prevents ~90% of cervical cancers.
  • Colorectal Cancer:
  • Colonoscopy: Every 10 years (45–75).
  • FOBT/FIT: Annual stool test (less invasive, lower sensitivity).
  • Lung Cancer:
  • Low-Dose CT: Annual for 50–80-year-olds with 20+ pack-year smoking history.

3. Well-Child Visits

  • Frequency:
  • 0–12 months: 7 visits (birth, 1, 2, 4, 6, 9, 12 months).
  • 1–4 years: Annual visits.
  • 5–18 years: Every 1–2 years.
  • Components:
  • Physical Exam: Heart, lungs, hips (for dysplasia), vision/hearing.
  • Developmental Screening: ASQ-3 (communication, motor skills).
  • Immunisations: Per schedule (e.g., MMR at 12 months).
  • Lab Tests: Lead screening (12–24 months), anemia (12 months), cholesterol (9–11 years).

Hands-On / Getting Started

Prerequisites

  • Knowledge: Basic anatomy, vaccine mechanisms, screening guidelines.
  • Tools:
  • Immunisation: Vaccine information statements (VIS), sharps container, alcohol swabs.
  • Screening: Mammogram/colonoscopy referrals, lab requisition forms.
  • Well-Child: Growth charts, ASQ-3 questionnaire, stethoscope.

Step-by-Step: Administering a Vaccine

  1. Verify Patient & Vaccine:
  2. Check name, DOB, allergies (e.g., egg allergy for flu vaccine).
  3. Confirm vaccine type, lot number, expiration date.
  4. Prepare Equipment:
  5. Draw up vaccine (e.g., 0.5 mL for DTaP).
  6. Use 23–25G needle (IM: 1–1.5 inch; SC: 5/8 inch).
  7. Administer:
  8. IM: Deltoid (adults), vastus lateralis (infants).
  9. SC: Upper arm (MMR, varicella).
  10. Aspirate? No (CDC recommends against for vaccines).
  11. Document:
  12. Vaccine name, dose, site, lot number, date, VIS provided.
  13. Example entry: plaintext 05/15/2024: DTaP (0.5 mL) IM R deltoid, Lot #A1234, VIS given.
  14. Monitor for Reactions:
  15. Mild: Redness, low-grade fever.
  16. Severe: Anaphylaxis (epinephrine 0.01 mg/kg IM).

Expected Outcome

  • Patient receives correct vaccine on schedule.
  • No adverse reactions; documentation is complete and legible.
  • Parent/patient understands next dose timing (e.g., "Next DTaP in 2 months").

Common Pitfalls & Mistakes

Mistake Why It Happens How to Avoid
Wrong vaccine dose Misreading syringe or age-based dose. Double-check dose (e.g., HepB: 0.5 mL for infants, 1 mL for adults).
Missed contraindications Not reviewing allergies/immunocompromised status. Ask: "Any allergies to eggs, gelatin, or previous vaccines?"
Incorrect injection site Using gluteal muscle (risk of sciatic nerve damage). Infants: vastus lateralis; adults: deltoid.
Overlooking catch-up schedules Assuming "one size fits all" for missed doses. Use CDC catch-up calculator (link).
False reassurance in screening Assuming a negative test = no cancer. Explain limitations (e.g., mammograms miss 10% of breast cancers).

Best Practices

Immunisations

  • Use standing orders to reduce errors (e.g., "All 12-month-olds receive MMR").
  • Store vaccines properly: 2–8°C (36–46°F); never freeze.
  • Address vaccine hesitancy:
  • Acknowledge concerns (e.g., "I understand you’re worried about side effects").
  • Provide evidence (e.g., "The MMR vaccine does not cause autism—here’s the data").
  • Use motivational interviewing (e.g., "What would make you feel more comfortable?").

Cancer Screening

  • Risk-stratify patients:
  • High-risk: BRCA mutation-annual MRI + mammogram.
  • Average-risk: Follow USPSTF guidelines.
  • Follow up on abnormal results:
  • Pap smear ASC-US: Repeat in 1 year or HPV test.
  • Positive FOBT: Refer for colonoscopy.
  • Document shared decision-making:
  • Example: "Patient declined colonoscopy; opted for annual FIT testing."

Well-Child Visits

  • Use standardized tools:
  • ASQ-3 for development.
  • PHQ-9 for adolescent depression screening.
  • Plot growth charts at every visitcrossing percentiles may indicate failure to thrive.
  • Provide written anticipatory guidance (e.g., "Safe sleep: back to sleep, no blankets").

Tools & Frameworks

Tool/Framework Use Case Example
CDC Vaccine Schedules Reference for U.S. immunisation timing. CDC Child Schedule
WHO Immunization App Global vaccine schedules and catch-up tools. WHO App
ASQ-3 Developmental screening for children 1–66 months. ASQ-3 Website
USPSTF Guidelines Evidence-based cancer screening recommendations. USPSTF
Epic/EMR Templates Pre-built documentation for well-child visits. "Well-Child Visit: 12 Months" template.
Vaccine Information Statements (VIS) Mandatory patient education materials. CDC VIS

Real-World Use Cases

1. School Nurse: Immunisation Compliance

  • Scenario: A parent brings a 5-year-old for a kindergarten physical but lacks records of MMR and varicella vaccines.
  • Action:
  • Check state requirements (e.g., 2 MMR doses for school entry).
  • Administer catch-up doses (minimum 4 weeks apart).
  • Provide VIS and document in the state registry.
  • Outcome: Child meets school requirements; herd immunity is maintained.

2. Primary Care: Breast Cancer Screening

  • Scenario: A 52-year-old woman with no family history of breast cancer asks if she needs a mammogram.
  • Action:
  • Explain USPSTF guidelines (biennial screening ages 50–74).
  • Discuss benefits (early detection) vs. risks (false positives, overdiagnosis).
  • Order 3D mammogram and schedule follow-up.
  • Outcome: Patient makes an informed decision; potential cancer detected early.

3. Pediatrician: Developmental Delay Detection

  • Scenario: A 24-month-old scores below cutoff on ASQ-3 communication domain.
  • Action:
  • Refer to early intervention services (e.g., speech therapy).
  • Re-screen in 3 months.
  • Counsel parents on language stimulation (e.g., reading daily).
  • Outcome: Child receives early therapy, improving long-term outcomes.

Check Your Understanding (MCQs)

Question 1

A 6-month-old infant presents for a well-child visit. Which vaccines are recommended at this age per the U.S. CDC schedule? A) DTaP, Hib, IPV, PCV13, Rotavirus, HepB B) MMR, Varicella, HepA C) Tdap, HPV, MenACWY D) Influenza, COVID-19

Correct Answer: A - Explanation: The 6-month visit includes DTaP, Hib, IPV, PCV13, Rotavirus, and HepB (3rd dose). MMR/Varicella start at 12 months; Tdap/HPV at 11–12 years. - Why the Distractors Are Tempting: - B) MMR/Varicella are given at 12 months, not 6. - C) Tdap/HPV are adolescent vaccines. - D) Influenza can be given at 6 months, but it’s not part of the core schedule.


Question 2

A 30-year-old woman with no family history of cervical cancer asks when she should get her next Pap smear. What is the most appropriate recommendation? A) Every year B) Every 3 years C) Every 5 years with HPV testing D) No screening needed until age 40

Correct Answer: C - Explanation: USPSTF recommends Pap smear every 3 years (21–29) or every 5 years with HPV testing (30–65). - Why the Distractors Are Tempting: - A) Annual Pap smears are outdated (increased false positives). - B) Correct for 21–29, but 30+ can extend to 5 years with HPV testing. - D) Screening starts at 21, regardless of family history.


Question 3

A 45-year-old man with a 20-pack-year smoking history asks about lung cancer screening. What is the most appropriate next step? A) Order a chest X-ray B) Recommend annual low-dose CT scan C) Advise smoking cessation and re-evaluate in 5 years D) No screening needed unless symptomatic

Correct Answer: B - Explanation: USPSTF recommends annual low-dose CT for 50–80-year-olds with a 20+ pack-year history who currently smoke or quit within 15 years. - Why the Distractors Are Tempting: - A) Chest X-rays are not recommended (poor sensitivity). - C) Smoking cessation is critical but does not replace screening. - D) Screening is recommended for high-risk asymptomatic individuals.


Learning Path

Beginner (0–6 months)

  1. Memorize vaccine schedules (CDC/WHO).
  2. Practice administering vaccines (IM/SC techniques).
  3. Learn USPSTF screening guidelines (breast, cervical, colorectal).
  4. Observe well-child visits (growth charts, ASQ-3).

Intermediate (6–1